← SynDRA
EXISULIND
SynDRA canonical compound SYN0011606 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PDE2A | PDE5A |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
- PDE5A
- Akr1b1
- EDNRA
- MAPK1
- PDE2A
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
- PDE5A MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCC2
- NPSR1
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MBNL1
- MAPT
- MAPK3
- MAPK14
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HSD17B10
- HRH2
- HRH1
- HMGCR
- HIF1A
- HDAC6
- GMNN
- MPHOSPH8
- NPY1R
- ACHE
- NPY2R
- TSHR
- TDP1
- TBXAS1
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- PTPRC
- PTGS2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Anticarcinogenic Agents
- Antineoplastic Agents
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Protective Agents
- Sensory System Agents
Cross-references
Synonyms
- aptosyn
- sulindac sulfone
- Aptosyn
- Prevatec
- Sulindac sulfone
- Sulindac sulphone
- FGN-1
- Sulindac related compound b
- Aposulind
- Prevatac (former Brand Name)
- (Z)-5-Fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-indene-3-acetic acid
- Sulindac Sulfone
- K619IIG2R9
- DTXCID4020246
- CHEBI:64212
- NSC719619
- OSIP-486823
- CP 248
- exisulindum
- OSIP486823
- RefChem:139763
- FGN 1
- Exisulind [INN]
- (Z)-Sulindac Sulfone
- SULINDAC SULPHONE
- C20H17FO4S
- NCGC00015928-04
- CAS-59973-80-7
- CCRIS 7242
- Sulindac EP Impurity B
- UNII-K619IIG2R9
- Sulindacsulfone
- MFCD00871143
- Sulindac Impurity 91
- ExisulindSulindac sulfon
- Curator_000028
- EXISULIND [MI]
Look up EXISULIND in the interactive SynDRA portal →